<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. ___)*
drkoop.com, Inc.
------------------------------
(Name of Issuer)
Common Stock, par value $0.001 per share
------------------------------
(Title of Class of Securities)
262098106
------------------------------
(CUSIP Number)
December 31, 1999
------------------------------
(Date of Event Which Requires Filing of this Statement)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
Rule 13d-1(b)
-----
Rule 13d-1(c)
-----
X Rule 13d-1(d)
-----
Page 1 of 6 pages
<PAGE>
CUSIP No. 262098106
- --------------------------------------------------------------------------------
1. Name of Reporting Person and I.R.S. Identification Number of Reporting
Person (Entities Only)
C. Everett Koop, M.D.
- --------------------------------------------------------------------------------
2. Check the Appropriate Row if a Member of a Group
a. N/A
b. N/A
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization
U. S. citizen
- --------------------------------------------------------------------------------
Number of Shares Beneficially Owned by Each Reporting Person With:
5. Sole Voting Power 1,689,709 shares (see Item 4)
6. Shared Voting Power 920,402 shares (see Item 4)
7. Sole Dispositive Power 1,689,709 shares (see Item 4)
8. Shared Dispositive Power 920,402 shares (see Item 4)
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,610,111 shares (see Item 4)
- --------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
N/A
- --------------------------------------------------------------------------------
Page 2 of 6 pages
<PAGE>
11. Percent of Class Represented by Amount in Row (9)
8.3%
- --------------------------------------------------------------------------------
12. Type of Reporting Person
IN
- --------------------------------------------------------------------------------
Page 3 of 6 pages
<PAGE>
Item 1(a). Name of Issuer:
drkoop.com, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
7000 North MoPac Expressway, Suite 400
Austin, Texas 78731
Item 2(a). Name of Person Filing:
C. Everett Koop, M.D.
Item 2(b). Address of Principal Business Office or, if None, Residence:
7000 North MoPac Expressway, Suite 400
Austin, Texas 78731
Item 2(c). Citizenship/State of Organization:
U. S. citizen
Item 2(d). Title of Class of Securities:
Common Stock, par value $0.001 per share
Item 2(e). CUSIP Number:
262098106
Item 3. Filing pursuant to Rule 13d-1(b) or 13d-2(b) or (c):
N/A
Item 4. Ownership:
(a) Amount Beneficially Owned: 2,610,111 shares
(b) Percent of Class: 8.3%
(c) Number of shares as to which such person has:
(i) sole power to vote or direct the vote: 1,689,709
shares (1)
(ii) shared power to vote or to direct the vote: 920,402
shares (2)
(iii) sole power to dispose or to direct the disposition
of: 1,689,709 shares (1)
Page 4 of 6 pages
<PAGE>
(iv) shared power to dispose or to direct the disposition
of: 920,402 shares (2)
(1) The 1,689,709 shares of common stock over which Dr. Koop has sole
voting and investment power include 777,244 shares underlying options
exercisable within sixty days of December 31, 1999.
(2) The 920,402 shares of common stock over which Dr. Koop shares
voting and investment power include: (i) 500,000 shares held by Koop
Investment, L.P.; Dr. Koop and his spouse are the general partners of
this partnership and share voting and investment power with respect to
such shares; (ii) 2,800 shares held by Dr. Koop's spouse as to which
Dr. Koop shares voting and investment power; and (iii) 417,602 shares
held by C. Everett Koop Annuity Trust (the "Trust") for which Dr.
Koop's son-in-law serves as the trustee.
Item 5. Ownership of Five Percent or Less of a Class:
N/A
Item 6. Ownership of More than Five Percent on Behalf of Another Person:
See Item 4. The partners in Koop Investment, L.P. may be entitled to
certain allocations and distributions in respect of their respective
partnership interests (which may include dividends and proceeds of a
sale of such shares). Subject to the terms of the Trust, the trustee
may direct the receipt of dividends or proceeds of a sale of shares
held by the Trust.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company:
N/A
Item 8. Identification and Classification of Members of the Group:
N/A
Item 9. Notice of Dissolution of Group:
N/A
Item 10. Certification:
N/A
Page 5 of 6 pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Section 13G is true, complete and
correct.
Dated: February 9, 2000 /s/ C. EVERETT KOOP, M.D.
--------------------------------
C. Everett Koop, M.D.
Page 6 of 6 pages
